New search Hide text from Guidelines
C CARDIOVASCULAR SYSTEMThis group comprises substances used for the treatment of cardiovascular conditions.
Drugs used for the treatment of hypertension are classified in C02 - Antihypertensives, C03 - Diuretics, C07 - Beta blocking agents, C08 - Calcium channel blockers, and C09 - Agents acting on the renin-angiotensin system. For the classification of combination products of antihypertensives from different ATC groups, the following ranking should be used, from higher to lower precedence: C09, C07, C08, and C03.
C10 LIPID MODIFYING AGENTS
The DDDs are based on the treatment of hypercholesterolemia. |
C10A LIPID MODIFYING AGENTS, PLAIN
Pantethine, which is also used in the treatment of hyperlipidemi, is classified as a vitamin in A11HA.
C10AX Other lipid modifying agents
This group comprises all cholesterol and triglyceride reducers, which cannot be classified in the preceding groups.
Icosapent ethyl is classified in C10AX06 - omega-3-triglycerides incl. other esters and acids.
Sulodexide is classified in B01AB.
The DDD for evolocumab is based on dosing every second week. The DDD for volanesorsen is based on the treatment of familial chylomicronemia syndrome. |
ATC code | Name | DDD | U | Adm.R | Note |
C10AX08 | policosanol |
Last updated: 2024-01-26